Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 970

1.

Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.

Tsikitis VL, Larson DL, Wolff BG, Kennedy G, Diehl N, Qin R, Dozois EJ, Cima RR.

J Am Coll Surg. 2009 Jan;208(1):42-7. doi: 10.1016/j.jamcollsurg.2008.10.013.

PMID:
19228501
2.

Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?

Wang J, Kulaylat M, Rockette H, Hassett J, Rajput A, Dunn KB, Dayton M.

Ann Surg. 2009 Apr;249(4):559-63. doi: 10.1097/SLA.0b013e318197f2c8.

PMID:
19300237
3.

Lymph node evaluation and survival after curative resection of colon cancer: systematic review.

Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA.

J Natl Cancer Inst. 2007 Mar 21;99(6):433-41. Review.

PMID:
17374833
4.

Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.

Vaccaro CA, Im V, Rossi GL, Quintana GO, Benati ML, Perez de Arenaza D, Bonadeo FA.

Dis Colon Rectum. 2009 Jul;52(7):1244-50. doi: 10.1007/DCR.0b013e3181a65f0b.

PMID:
19571700
5.

Young age influences treatment but not outcome of colon cancer.

Quah HM, Joseph R, Schrag D, Shia J, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR.

Ann Surg Oncol. 2007 Oct;14(10):2759-65. Epub 2007 Jun 26.

PMID:
17593332
6.

Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer.

Johnson PM, Porter GA, Ricciardi R, Baxter NN.

J Clin Oncol. 2006 Aug 1;24(22):3570-5.

PMID:
16877723
7.

Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study.

Vather R, Sammour T, Kahokehr A, Connolly AB, Hill AG.

Ann Surg Oncol. 2009 Mar;16(3):585-93. doi: 10.1245/s10434-008-0265-8. Epub 2008 Dec 31.

PMID:
19116751
8.

Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer.

Law CH, Wright FC, Rapanos T, Alzahrani M, Hanna SS, Khalifa M, Smith AJ.

J Surg Oncol. 2003 Nov;84(3):120-6.

PMID:
14598354
9.

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.

Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG.

J Clin Oncol. 2003 Aug 1;21(15):2912-9.

PMID:
12885809
10.

Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival.

Moore J, Hyman N, Callas P, Littenberg B.

Surgery. 2010 Mar;147(3):358-65. doi: 10.1016/j.surg.2009.10.003. Epub 2009 Dec 3.

PMID:
19962166
11.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
12.

Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.

Hanna NN, Onukwugha E, Choti MA, Davidoff AJ, Zuckerman IH, Hsu VD, Mullins CD.

Colorectal Dis. 2012 Jan;14(1):48-55. doi: 10.1111/j.1463-1318.2011.02545.x.

PMID:
21689262
13.

A novel data-driven prognostic model for staging of colorectal cancer.

Manilich EA, Kiran RP, Radivoyevitch T, Lavery I, Fazio VW, Remzi FH.

J Am Coll Surg. 2011 Nov;213(5):579-588, 588.e1-2. doi: 10.1016/j.jamcollsurg.2011.08.006. Epub 2011 Sep 16.

PMID:
21925905
14.

The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery.

Galizia G, Orditura M, Ferraraccio F, Castellano P, Pinto M, Zamboli A, Cecere S, De Vita F, Pignatelli C, Lieto E.

World J Surg. 2009 Dec;33(12):2704-13. doi: 10.1007/s00268-009-0207-z.

PMID:
19760316
15.

Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy.

Briganti A, Karnes JR, Da Pozzo LF, Cozzarini C, Gallina A, Suardi N, Bianchi M, Freschi M, Doglioni C, Fazio F, Rigatti P, Montorsi F, Blute ML.

Eur Urol. 2009 Feb;55(2):261-70. doi: 10.1016/j.eururo.2008.09.043. Epub 2008 Oct 1.

PMID:
18838212
16.

The prognostic significance of total lymph node harvest in patients with T2-4N0M0 colorectal cancer.

Tsai HL, Lu CY, Hsieh JS, Wu DC, Jan CM, Chai CY, Chu KS, Chan HM, Wang JY.

J Gastrointest Surg. 2007 May;11(5):660-5.

PMID:
17468927
17.

The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined.

Swanson RS, Compton CC, Stewart AK, Bland KI.

Ann Surg Oncol. 2003 Jan-Feb;10(1):65-71.

PMID:
12513963
18.

Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center.

Fata F, Mirza A, Craig G, Nair S, Law A, Gallagher J, Ellison N, Bernath A.

Cancer. 2002 Apr 1;94(7):1931-8. Review.

19.

Nodal stage of stage III colon cancer: the impact of metastatic lymph node ratio.

Park IJ, Choi GS, Jun SH.

J Surg Oncol. 2009 Sep 1;100(3):240-3. doi: 10.1002/jso.21273.

PMID:
19330780
20.

lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.

Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee SW, Kim JC, Yu CS, Kim HC, Kim TW, Chang HM.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):796-802. doi: 10.1016/j.ijrobp.2008.08.065. Epub 2009 Mar 14.

PMID:
19289261

Supplemental Content

Support Center